| UniProt ID | TOIP1_HUMAN | |
|---|---|---|
| UniProt AC | Q5JTV8 | |
| Protein Name | Torsin-1A-interacting protein 1 | |
| Gene Name | TOR1AIP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 583 | |
| Subcellular Localization |
Nucleus inner membrane Single-pass membrane protein . |
|
| Protein Description | Required for nuclear membrane integrity. Induces TOR1A and TOR1B ATPase activity and is required for their location on the nuclear membrane. Binds to A- and B-type lamins. Possible role in membrane attachment and assembly of the nuclear lamina.. | |
| Protein Sequence | MAGDGRRAEAVREGWGVYVTPRAPIREGRGRLAPQNGGSSDAPAYRTPPSRQGRREVRFSDEPPEVYGDFEPLVAKERSPVGKRTRLEEFRSDSAKEEVRESAYYLRSRQRRQPRPQETEEMKTRRTTRLQQQHSEQPPLQPSPVMTRRGLRDSHSSEEDEASSQTDLSQTISKKTVRSIQEAPVSEDLVIRLRRPPLRYPRYEATSVQQKVNFSEEGETEEDDQDSSHSSVTTVKARSRDSDESGDKTTRSSSQYIESFWQSSQSQNFTAHDKQPSVLSSGYQKTPQEWAPQTARIRTRMQNDSILKSELGNQSPSTSSRQVTGQPQNASFVKRNRWWLLPLIAALASGSFWFFSTPEVETTAVQEFQNQMNQLKNKYQGQDEKLWKRSQTFLEKHLNSSHPRSQPAILLLTAARDAEEALRCLSEQIADAYSSFRSVRAIRIDGTDKATQDSDTVKLEVDQELSNGFKNGQNAAVVHRFESFPAGSTLIFYKYCDHENAAFKDVALVLTVLLEEETLGTSLGLKEVEEKVRDFLKVKFTNSNTPNSYNHMDPDKLNGLWSRISHLVLPVQPENALKRGICL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Sulfoxidation | -------MAGDGRRA -------CCCCCHHH | 9.44 | 30846556 | |
| 18 | Phosphorylation | VREGWGVYVTPRAPI HHCCCEEEECCCCCC | 8.48 | 29396449 | |
| 20 | Phosphorylation | EGWGVYVTPRAPIRE CCCEEEECCCCCCCC | 6.86 | 21815630 | |
| 39 | Phosphorylation | LAPQNGGSSDAPAYR CCCCCCCCCCCCCCC | 26.83 | 27732954 | |
| 40 | Phosphorylation | APQNGGSSDAPAYRT CCCCCCCCCCCCCCC | 40.86 | 27732954 | |
| 45 | Phosphorylation | GSSDAPAYRTPPSRQ CCCCCCCCCCCCCCC | 17.60 | 25002506 | |
| 47 | Phosphorylation | SDAPAYRTPPSRQGR CCCCCCCCCCCCCCC | 27.20 | 26055452 | |
| 50 | Phosphorylation | PAYRTPPSRQGRREV CCCCCCCCCCCCCEE | 38.14 | 26055452 | |
| 60 | Phosphorylation | GRREVRFSDEPPEVY CCCEEECCCCCCCCC | 30.42 | 21712546 | |
| 67 | Phosphorylation | SDEPPEVYGDFEPLV CCCCCCCCCCCHHCC | 14.87 | 24173317 | |
| 76 | Ubiquitination | DFEPLVAKERSPVGK CCHHCCCCCCCCCCC | 46.29 | 29967540 | |
| 79 | Phosphorylation | PLVAKERSPVGKRTR HCCCCCCCCCCCCHH | 25.65 | 25849741 | |
| 92 | Phosphorylation | TRLEEFRSDSAKEEV HHHHHHCCCHHHHHH | 41.04 | 25159151 | |
| 94 | Phosphorylation | LEEFRSDSAKEEVRE HHHHCCCHHHHHHHH | 42.35 | 25159151 | |
| 102 | Phosphorylation | AKEEVRESAYYLRSR HHHHHHHHHHHHHHH | 15.82 | 28555341 | |
| 115 | Methylation | SRQRRQPRPQETEEM HHCCCCCCCCCHHHH | 36.88 | 115386881 | |
| 127 | Phosphorylation | EEMKTRRTTRLQQQH HHHHHHHHHHHHHHH | 16.99 | 29116813 | |
| 128 | Phosphorylation | EMKTRRTTRLQQQHS HHHHHHHHHHHHHHC | 27.80 | 29116813 | |
| 135 | Phosphorylation | TRLQQQHSEQPPLQP HHHHHHHCCCCCCCC | 33.32 | 23401153 | |
| 143 | Phosphorylation | EQPPLQPSPVMTRRG CCCCCCCCCCCCCCC | 19.71 | 22167270 | |
| 146 | Sulfoxidation | PLQPSPVMTRRGLRD CCCCCCCCCCCCCCC | 2.47 | 21406390 | |
| 147 | Phosphorylation | LQPSPVMTRRGLRDS CCCCCCCCCCCCCCC | 19.90 | 22167270 | |
| 154 | Phosphorylation | TRRGLRDSHSSEEDE CCCCCCCCCCCHHHH | 20.87 | 29255136 | |
| 156 | Phosphorylation | RGLRDSHSSEEDEAS CCCCCCCCCHHHHHH | 43.31 | 29255136 | |
| 157 | Phosphorylation | GLRDSHSSEEDEASS CCCCCCCCHHHHHHC | 39.31 | 29255136 | |
| 163 | Phosphorylation | SSEEDEASSQTDLSQ CCHHHHHHCCCCHHH | 22.41 | 23927012 | |
| 164 | Phosphorylation | SEEDEASSQTDLSQT CHHHHHHCCCCHHHH | 44.11 | 23927012 | |
| 166 | Phosphorylation | EDEASSQTDLSQTIS HHHHHCCCCHHHHHC | 40.64 | 30278072 | |
| 169 | Phosphorylation | ASSQTDLSQTISKKT HHCCCCHHHHHCHHH | 28.25 | 17525332 | |
| 171 | Phosphorylation | SQTDLSQTISKKTVR CCCCHHHHHCHHHHC | 24.68 | 23927012 | |
| 173 | Phosphorylation | TDLSQTISKKTVRSI CCHHHHHCHHHHCHH | 31.33 | 23927012 | |
| 174 | Ubiquitination | DLSQTISKKTVRSIQ CHHHHHCHHHHCHHH | 48.92 | 21906983 | |
| 174 (in isoform 1) | Ubiquitination | - | 48.92 | 21890473 | |
| 174 (in isoform 2) | Ubiquitination | - | 48.92 | 21890473 | |
| 175 | Ubiquitination | LSQTISKKTVRSIQE HHHHHCHHHHCHHHH | 45.52 | 22817900 | |
| 176 | Phosphorylation | SQTISKKTVRSIQEA HHHHCHHHHCHHHHC | 25.53 | 23312004 | |
| 179 | Phosphorylation | ISKKTVRSIQEAPVS HCHHHHCHHHHCCCC | 25.04 | 29255136 | |
| 179 (in isoform 2) | Phosphorylation | - | 25.04 | 22777824 | |
| 179 (in isoform 3) | Phosphorylation | - | 25.04 | 22777824 | |
| 186 | O-linked_Glycosylation | SIQEAPVSEDLVIRL HHHHCCCCCCEEEEE | 25.08 | 30059200 | |
| 186 | Phosphorylation | SIQEAPVSEDLVIRL HHHHCCCCCCEEEEE | 25.08 | 21712546 | |
| 187 (in isoform 2) | Phosphorylation | - | 56.45 | 28122231 | |
| 187 (in isoform 3) | Phosphorylation | - | 56.45 | 28122231 | |
| 200 | Phosphorylation | LRRPPLRYPRYEATS ECCCCCCCCCCCCCC | 10.35 | - | |
| 203 | Nitration | PPLRYPRYEATSVQQ CCCCCCCCCCCCCHH | 12.86 | - | |
| 203 | Phosphorylation | PPLRYPRYEATSVQQ CCCCCCCCCCCCCHH | 12.86 | 28796482 | |
| 206 | Phosphorylation | RYPRYEATSVQQKVN CCCCCCCCCCHHCCC | 19.93 | 27422710 | |
| 211 | Ubiquitination | EATSVQQKVNFSEEG CCCCCHHCCCCCCCC | 23.27 | 23503661 | |
| 212 | Ubiquitination | ATSVQQKVNFSEEGE CCCCHHCCCCCCCCC | 8.32 | 23503661 | |
| 215 | Phosphorylation | VQQKVNFSEEGETEE CHHCCCCCCCCCCCC | 29.54 | 29255136 | |
| 216 | Phosphorylation | QQKVNFSEEGETEED HHCCCCCCCCCCCCC | 66.92 | 27251275 | |
| 220 | Phosphorylation | NFSEEGETEEDDQDS CCCCCCCCCCCCCCC | 56.37 | 19664994 | |
| 221 | Phosphorylation | FSEEGETEEDDQDSS CCCCCCCCCCCCCCC | 55.94 | 32645325 | |
| 227 | Phosphorylation | TEEDDQDSSHSSVTT CCCCCCCCCCCCEEE | 25.07 | 30266825 | |
| 228 | Phosphorylation | EEDDQDSSHSSVTTV CCCCCCCCCCCEEEE | 35.36 | 22167270 | |
| 229 | Phosphorylation | EDDQDSSHSSVTTVK CCCCCCCCCCEEEEE | 28.22 | 27251275 | |
| 230 | Phosphorylation | DDQDSSHSSVTTVKA CCCCCCCCCEEEEEE | 28.58 | 22167270 | |
| 231 | Phosphorylation | DQDSSHSSVTTVKAR CCCCCCCCEEEEEEE | 20.33 | 22167270 | |
| 232 | Phosphorylation | QDSSHSSVTTVKARS CCCCCCCEEEEEEEC | 6.12 | 27251275 | |
| 233 | Phosphorylation | DSSHSSVTTVKARSR CCCCCCEEEEEEECC | 28.02 | 22167270 | |
| 234 | Phosphorylation | SSHSSVTTVKARSRD CCCCCEEEEEEECCC | 20.18 | 22167270 | |
| 236 | Ubiquitination | HSSVTTVKARSRDSD CCCEEEEEEECCCCC | 35.67 | 21906983 | |
| 236 (in isoform 2) | Ubiquitination | - | 35.67 | 21890473 | |
| 237 | Ubiquitination | SSVTTVKARSRDSDE CCEEEEEEECCCCCC | 15.45 | 21963094 | |
| 237 (in isoform 1) | Ubiquitination | - | 15.45 | 21890473 | |
| 239 | Phosphorylation | VTTVKARSRDSDESG EEEEEEECCCCCCCC | 45.35 | 30242111 | |
| 242 | Phosphorylation | VKARSRDSDESGDKT EEEECCCCCCCCCCC | 42.01 | 28176443 | |
| 245 | Phosphorylation | RSRDSDESGDKTTRS ECCCCCCCCCCCCCC | 58.23 | 28176443 | |
| 248 | Ubiquitination | DSDESGDKTTRSSSQ CCCCCCCCCCCCHHH | 56.15 | 33845483 | |
| 249 | Phosphorylation | SDESGDKTTRSSSQY CCCCCCCCCCCHHHH | 31.98 | 24247654 | |
| 249 | Ubiquitination | SDESGDKTTRSSSQY CCCCCCCCCCCHHHH | 31.98 | 33845483 | |
| 250 | Phosphorylation | DESGDKTTRSSSQYI CCCCCCCCCCHHHHH | 34.00 | 27251275 | |
| 252 | Phosphorylation | SGDKTTRSSSQYIES CCCCCCCCHHHHHHH | 32.05 | 21712546 | |
| 253 | Phosphorylation | GDKTTRSSSQYIESF CCCCCCCHHHHHHHH | 20.40 | 27794612 | |
| 254 | Phosphorylation | DKTTRSSSQYIESFW CCCCCCHHHHHHHHH | 28.40 | 17525332 | |
| 256 | Phosphorylation | TTRSSSQYIESFWQS CCCCHHHHHHHHHHH | 14.49 | 25884760 | |
| 259 | Phosphorylation | SSSQYIESFWQSSQS CHHHHHHHHHHHCCC | 23.40 | 23403867 | |
| 263 | Phosphorylation | YIESFWQSSQSQNFT HHHHHHHHCCCCCCC | 22.42 | 23403867 | |
| 264 | Phosphorylation | IESFWQSSQSQNFTA HHHHHHHCCCCCCCC | 20.81 | 23403867 | |
| 266 | Phosphorylation | SFWQSSQSQNFTAHD HHHHHCCCCCCCCCC | 29.10 | 17525332 | |
| 270 | O-linked_Glycosylation | SSQSQNFTAHDKQPS HCCCCCCCCCCCCCC | 30.54 | 30059200 | |
| 270 | Phosphorylation | SSQSQNFTAHDKQPS HCCCCCCCCCCCCCC | 30.54 | 23403867 | |
| 274 | Ubiquitination | QNFTAHDKQPSVLSS CCCCCCCCCCCHHCC | 55.00 | 22817900 | |
| 275 | Ubiquitination | NFTAHDKQPSVLSSG CCCCCCCCCCHHCCC | 41.37 | 21890473 | |
| 277 | Phosphorylation | TAHDKQPSVLSSGYQ CCCCCCCCHHCCCCC | 32.94 | 25159151 | |
| 280 | Phosphorylation | DKQPSVLSSGYQKTP CCCCCHHCCCCCCCH | 21.40 | 25159151 | |
| 281 | Phosphorylation | KQPSVLSSGYQKTPQ CCCCHHCCCCCCCHH | 37.04 | 25159151 | |
| 285 | Ubiquitination | VLSSGYQKTPQEWAP HHCCCCCCCHHHHCC | 54.40 | 22817900 | |
| 286 | Phosphorylation | LSSGYQKTPQEWAPQ HCCCCCCCHHHHCCC | 18.06 | 25159151 | |
| 286 | Ubiquitination | LSSGYQKTPQEWAPQ HCCCCCCCHHHHCCC | 18.06 | 21890473 | |
| 287 | Phosphorylation | SSGYQKTPQEWAPQT CCCCCCCHHHHCCCH | 36.81 | 27251275 | |
| 294 | Phosphorylation | PQEWAPQTARIRTRM HHHHCCCHHHHHHHH | 19.49 | 25159151 | |
| 300 | Methylation | QTARIRTRMQNDSIL CHHHHHHHHHCCHHH | 18.16 | 115918745 | |
| 305 | Phosphorylation | RTRMQNDSILKSELG HHHHHCCHHHHHHHC | 37.05 | 23401153 | |
| 308 | Sumoylation | MQNDSILKSELGNQS HHCCHHHHHHHCCCC | 39.97 | 28112733 | |
| 308 | Ubiquitination | MQNDSILKSELGNQS HHCCHHHHHHHCCCC | 39.97 | 23000965 | |
| 309 | Phosphorylation | QNDSILKSELGNQSP HCCHHHHHHHCCCCC | 34.31 | 28176443 | |
| 309 | Ubiquitination | QNDSILKSELGNQSP HCCHHHHHHHCCCCC | 34.31 | 23000965 | |
| 309 (in isoform 1) | Ubiquitination | - | 34.31 | 21890473 | |
| 315 | Phosphorylation | KSELGNQSPSTSSRQ HHHHCCCCCCCCCCC | 25.47 | 29255136 | |
| 316 | Phosphorylation | SELGNQSPSTSSRQV HHHCCCCCCCCCCCC | 31.68 | 27251275 | |
| 317 | Phosphorylation | ELGNQSPSTSSRQVT HHCCCCCCCCCCCCC | 46.28 | 23401153 | |
| 318 | Phosphorylation | LGNQSPSTSSRQVTG HCCCCCCCCCCCCCC | 33.82 | 30266825 | |
| 319 | Phosphorylation | GNQSPSTSSRQVTGQ CCCCCCCCCCCCCCC | 28.06 | 30266825 | |
| 320 | Phosphorylation | NQSPSTSSRQVTGQP CCCCCCCCCCCCCCC | 27.16 | 30266825 | |
| 324 | Phosphorylation | STSSRQVTGQPQNAS CCCCCCCCCCCCCCH | 23.04 | 26074081 | |
| 331 | Phosphorylation | TGQPQNASFVKRNRW CCCCCCCHHHHHCHH | 37.81 | 22210691 | |
| 334 | 2-Hydroxyisobutyrylation | PQNASFVKRNRWWLL CCCCHHHHHCHHHHH | 41.78 | - | |
| 334 | Acetylation | PQNASFVKRNRWWLL CCCCHHHHHCHHHHH | 41.78 | 26051181 | |
| 334 | Ubiquitination | PQNASFVKRNRWWLL CCCCHHHHHCHHHHH | 41.78 | 27667366 | |
| 335 | Ubiquitination | QNASFVKRNRWWLLP CCCHHHHHCHHHHHH | 32.42 | 21890473 | |
| 335 (in isoform 1) | Ubiquitination | - | 32.42 | 21890473 | |
| 349 | Ubiquitination | PLIAALASGSFWFFS HHHHHHHHCCEEECC | 35.50 | 21890473 | |
| 350 | Ubiquitination | LIAALASGSFWFFST HHHHHHHCCEEECCC | 22.66 | 21890473 | |
| 351 (in isoform 2) | Ubiquitination | - | 19.46 | 21890473 | |
| 379 | Phosphorylation | MNQLKNKYQGQDEKL HHHHHHHHCCCCHHH | 27.54 | - | |
| 385 | Acetylation | KYQGQDEKLWKRSQT HHCCCCHHHHHHHHH | 68.86 | 26051181 | |
| 385 | Ubiquitination | KYQGQDEKLWKRSQT HHCCCCHHHHHHHHH | 68.86 | 29967540 | |
| 386 | Ubiquitination | YQGQDEKLWKRSQTF HCCCCHHHHHHHHHH | 6.49 | 29967540 | |
| 399 | N-linked_Glycosylation | TFLEKHLNSSHPRSQ HHHHHHHCCCCCCCC | 40.98 | 19159218 | |
| 399 | N-linked_Glycosylation | TFLEKHLNSSHPRSQ HHHHHHHCCCCCCCC | 40.98 | 20068230 | |
| 400 | O-linked_Glycosylation | FLEKHLNSSHPRSQP HHHHHHCCCCCCCCH | 36.06 | 30059200 | |
| 405 | Phosphorylation | LNSSHPRSQPAILLL HCCCCCCCCHHHHHH | 44.99 | 21712546 | |
| 424 | Glutathionylation | DAEEALRCLSEQIAD CHHHHHHHHHHHHHH | 5.22 | 22555962 | |
| 449 | Ubiquitination | IRIDGTDKATQDSDT EEECCCCCCCCCCCC | 53.85 | 24816145 | |
| 450 | Ubiquitination | RIDGTDKATQDSDTV EECCCCCCCCCCCCE | 17.19 | 24816145 | |
| 464 | Ubiquitination | VKLEVDQELSNGFKN EEEEECHHHHHCCCC | 50.10 | 24816145 | |
| 465 | Ubiquitination | KLEVDQELSNGFKNG EEEECHHHHHCCCCC | 3.91 | 24816145 | |
| 466 | Phosphorylation | LEVDQELSNGFKNGQ EEECHHHHHCCCCCC | 33.87 | 27251275 | |
| 467 | Phosphorylation | EVDQELSNGFKNGQN EECHHHHHCCCCCCC | 72.97 | 27251275 | |
| 488 | Phosphorylation | FESFPAGSTLIFYKY EECCCCCCEEEEEEE | 23.34 | 27251275 | |
| 489 | Phosphorylation | ESFPAGSTLIFYKYC ECCCCCCEEEEEEEC | 23.97 | 27251275 | |
| 539 | Ubiquitination | VRDFLKVKFTNSNTP HHHHHEEEECCCCCC | 44.90 | 29967540 | |
| 540 | Ubiquitination | RDFLKVKFTNSNTPN HHHHEEEECCCCCCC | 9.77 | 29967540 | |
| 543 | Phosphorylation | LKVKFTNSNTPNSYN HEEEECCCCCCCCCC | 38.74 | 20068231 | |
| 556 | Acetylation | YNHMDPDKLNGLWSR CCCCCHHHCCCHHHH | 49.60 | 26051181 | |
| 556 | Ubiquitination | YNHMDPDKLNGLWSR CCCCCHHHCCCHHHH | 49.60 | 22817900 | |
| 557 | Ubiquitination | NHMDPDKLNGLWSRI CCCCHHHCCCHHHHH | 8.84 | 21890473 | |
| 571 | Ubiquitination | ISHLVLPVQPENALK HHHHHCCCCCHHHHH | 15.04 | 21890473 | |
| 572 | Ubiquitination | SHLVLPVQPENALKR HHHHCCCCCHHHHHC | 37.34 | 21890473 | |
| 578 | 2-Hydroxyisobutyrylation | VQPENALKRGICL-- CCCHHHHHCCCCC-- | 46.28 | - | |
| 578 | Ubiquitination | VQPENALKRGICL-- CCCHHHHHCCCCC-- | 46.28 | 24816145 | |
| 579 | Ubiquitination | QPENALKRGICL--- CCHHHHHCCCCC--- | 40.33 | 24816145 | |
| 593 | Ubiquitination | ----------------- ----------------- | 24816145 | ||
| 594 | Ubiquitination | ------------------ ------------------ | 24816145 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 143 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TOIP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TOIP1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| LMNA_HUMAN | LMNA | physical | 16248985 | |
| TOR1A_HUMAN | TOR1A | physical | 20861018 | |
| TOR1A_HUMAN | TOR1A | physical | 15767459 | |
| TOR1A_HUMAN | TOR1A | physical | 23569223 | |
| TOR1A_HUMAN | TOR1A | physical | 25352667 | |
| IF4G1_HUMAN | EIF4G1 | physical | 26496610 | |
| PPM1A_HUMAN | PPM1A | physical | 26496610 | |
| THIO_HUMAN | TXN | physical | 26496610 | |
| UBP1_HUMAN | USP1 | physical | 26496610 | |
| AIFM1_HUMAN | AIFM1 | physical | 26496610 | |
| GT2D1_HUMAN | GTF2IRD1 | physical | 26496610 | |
| NARF_HUMAN | NARF | physical | 26496610 | |
| CSN7A_HUMAN | COPS7A | physical | 26496610 | |
| PIGT_HUMAN | PIGT | physical | 26496610 | |
| MIC19_HUMAN | CHCHD3 | physical | 26496610 | |
| MREG_HUMAN | MREG | physical | 26496610 | |
| IPO4_HUMAN | IPO4 | physical | 26496610 | |
| PEAK1_HUMAN | PEAK1 | physical | 26496610 | |
| MIA40_HUMAN | CHCHD4 | physical | 26496610 | |
| KLH15_HUMAN | KLHL15 | physical | 28514442 | |
| MD2BP_HUMAN | MAD2L1BP | physical | 28514442 | |
| AIFM1_HUMAN | AIFM1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-399, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154; SER-156; SER-157;SER-215; THR-220; SER-227 AND SER-305, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-215; THR-220 ANDSER-315, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135; SER-143; SER-154;SER-156; SER-157; SER-186; SER-215; THR-220; SER-305; SER-315 ANDSER-317, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143 AND SER-315, ANDMASS SPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154; SER-156; SER-164;SER-169 AND SER-266, AND MASS SPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143; SER-154; SER-163AND THR-220, AND MASS SPECTROMETRY. | |